Ningbo Menovo Pharm Co Ltd
医疗健康 · 专科与仿制药
Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. The company's products portfolio includes valsartan, losartan, clopidogrel, perindopril, rosuvastatin calcium, atorvastatin calcium, purin bahrain, and other products. It offers APIs, intermediates, and preparations for the treatment of cardiovascular, central nervous system, gastrointestinal tract, and other therapeutic areas. The company was founded in 2004 and is headquartered in Ningbo, China.
MARKET 市值 11.22B CNY PE 91.7x
52W ¥18.97 – ¥70.39
EODHD · Q 2026-03-31 · 同步 2026-07-14
QUALITY PEG — 营收 YoY 22.1%
▲ ROE 4.8% 营业利润率 13.0% 净利润率 7.2%
ANALYST 股息率 0.36%